A new study reveals that GLP-1 drugs may affect medical scan results, though experts say findings are preliminary and more ...
A doctor has issued a warning over a worrying new side effect of drugs used to aid weight loss. Drugs such as Mounjaro, ...
The rise of GLP-1s prescribed for weight loss and type 2 diabetes is leading to potentially misleading patterns in cancer scans.
Experts warn the strange side effect could lead to delayed diagnoses and treatments, as well as unnecessary medical ...
The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET-CT scans, new research ...
MedPage Today on MSN
GLP-1s May Throw Off Some Medical Scans
GLP-1 receptor agonists have long half-lives so a patient would need to stop taking it a month before a scan for it to completely eliminate the risk of it influencing the imaging. Gadaleta noted that ...
PET scans can light up tumors in the body and help doctors determine if they are cancerous or benign (noncancerous). The results of a PET scan help guide medical decisions. A PET scan is a type of ...
Health and Me on MSN
Unusual Ozempic Side-Effect: Study Finds Weight Loss Jabs May Interfere With PET-CT Imaging Scans
Ozempic and other weight loss jabs have recently gained a lot of fame, as people rush to buy and use them. However, many ...
PET scans may serve as both a diagnostic and prognostic tool in giant cell arteritis (GCA), according to a new study. In over 100 patients with GCA who underwent 18 F-fluorodeoxyglucose (FDG) PET ...
Positron emission tomography (PET) is a type of imaging scan that doctors might use when diagnosing and treating non-Hodgkin’s lymphoma (NHL). It can be useful for identifying and staging the cancer.
A PET imaging study reveals widespread synaptic AMPAR increases in long COVID patients with cognitive impairment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results